Kyle Malady, EVP and Group CEO-VZ Business at Verizon Communications Inc., filed a Form 4 on November 12, 2026, reporting the sale of 1,100 shares of Verizon common stock on November 10, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Transaction: Malady disposed of 1,100 shares of Verizon common stock on November 10, 2026, at a price of $46.11 per share.
  • 10b5-1 Plan: The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Malady on May 18, 2026.
  • Direct Holdings After Transaction: Following the sale, Malady directly beneficially owned 96,666 shares of common stock.
  • Indirect Holdings: Malady also holds 20,527 shares indirectly through a 401(k) plan.
  • Reporting Person Role: Malady is identified in the filing as EVP and Group CEO-VZ Business of Verizon Communications Inc.
  • Signatory: The form was signed by Evgeniya Berezkina as attorney-in-fact for Kyle Malady on November 12, 2026.

Malady's November 2026 Share Disposition Under Pre-Established Trading Plan

According to the filing, Kyle Malady, identified as EVP and Group CEO-VZ Business, sold 1,100 shares of Verizon Communications Inc. (NYSE:VZ) common stock on November 10, 2026, at a price of $46.11 per share. The filing indicates the transaction was coded "S" (a sale) and that the shares were disposed of directly. The filing notes that the box was checked to indicate the transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

As explained in the filing's footnote, the sale was executed under a Rule 10b5-1 trading plan that Malady adopted on May 18, 2026. Following the reported transaction, the filing states Malady directly held 96,666 shares of Verizon common stock. In addition, the filing reports 20,527 shares held indirectly through a 401(k) plan, bringing total reported beneficial ownership across both direct and indirect holdings to 117,193 shares.

No derivative securities were reported as acquired or disposed of in this filing. The Form 4 was filed on November 12, 2026, and covers the earliest transaction date of November 10, 2026. Evgeniya Berezkina signed the form as attorney-in-fact for Malady on the filing date.

What Was Disclosed

The filing reports a single open-market sale of 1,100 Verizon common shares by Kyle Malady on November 10, 2026, at $46.11 per share, executed under a pre-established Rule 10b5-1 plan adopted May 18, 2026, leaving Malady with 96,666 directly held shares and 20,527 shares held through a 401(k).